Zafar's professional journey transitioned from being a patient diagnosed with bipolar disorder to investigating treatments for the condition at a molecular level.
In a meta-analysis, cognitive impairment manifested in deficits in attention, memory, and executive function in a substantial number of patients, depending on the level of illness severity.
